{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:59:11Z","timestamp":1790740751095,"version":"4.1.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10461-024-04491-z","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T11:01:44Z","timestamp":1727521304000},"page":"101-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Systematic Review and Narrative Synthesis of Factors Affecting Pre-exposure Prophylaxis Willingness Among Black Women for HIV Prevention"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-9958","authenticated-orcid":false,"given":"Alexis","family":"Sims Haynes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0587-894X","authenticated-orcid":false,"given":"Christine","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1976-5145","authenticated-orcid":false,"given":"Vanessa","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3754","authenticated-orcid":false,"given":"Robert","family":"Suchting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1922-0639","authenticated-orcid":false,"given":"Nivedhitha","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-5897","authenticated-orcid":false,"given":"Sumaita","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9778-358X","authenticated-orcid":false,"given":"Mandy J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"10279","key":"4491_CR1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/S0140-6736(21)00395-0","volume":"397","author":"PS Sullivan","year":"2021","unstructured":"Sullivan PS, Satcher Johnson A, Pembleton ES, et al. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. The Lancet. 2021;397(10279):1095\u201306. https:\/\/doi.org\/10.1016\/S0140-6736(21)00395-0.","journal-title":"The Lancet"},{"key":"4491_CR2","unstructured":"CDC. HIV surveillance | reports| resource library | HIV\/AIDS | CDC. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Updated 2024."},{"key":"4491_CR3","unstructured":"CDC. Black americans and HIV\/AIDS: The basics The Henry J. Kaiser Family Foundation Web site. https:\/\/www.kff.org\/hivaids\/fact-sheet\/black-americans-and-hivaids-the-basics\/. Updated 2018."},{"issue":"13","key":"4491_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1097\/QAD.0b013e3283629037","volume":"27","author":"PM Murnane","year":"2013","unstructured":"Murnane PM, Celum C, Mugo N, et al. Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial. AIDS. 2013;27(13):2155\u201360. https:\/\/doi.org\/10.1097\/QAD.0b013e3283629037.","journal-title":"AIDS"},{"issue":"2","key":"4491_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11904-011-0078-4","volume":"8","author":"T Kelesidis","year":"2011","unstructured":"Kelesidis T, Landovitz RJ. Preexposure prophylaxis for HIV prevention. Curr HIV\/AIDS Rep. 2011;8(2):94\u2013103. https:\/\/doi.org\/10.1007\/s11904-011-0078-4.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"4491_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.annepidem.2017.02.003","volume":"27","author":"KL Hess","year":"2017","unstructured":"Hess KL, Hu X, Lansky A, Mermin J, Hall HI. Lifetime risk of a diagnosis of HIV infection in the united states. Ann Epidemiol. 2017;27(4):238\u201343. https:\/\/doi.org\/10.1016\/j.annepidem.2017.02.003.","journal-title":"Ann Epidemiol"},{"key":"4491_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-6301-0","author":"Y Ransome","year":"2018","unstructured":"Ransome Y, Bogart LM, Nunn AS, Mayer KH, Sadler KR, Ojikutu BO. Faith leaders\u2019 messaging is essential to enhance HIV prevention among black Americans: results from the 2016 national survey on HIV in the black community (NSHBC). BMC Public Health. 2018. https:\/\/doi.org\/10.1186\/s12889-018-6301-0.","journal-title":"BMC Public Health"},{"issue":"1","key":"4491_CR8","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1097\/QAI.0b013e3182920126","volume":"63","author":"GM Wingood","year":"2013","unstructured":"Wingood GM, Dunkle K, Camp C, et al. Racial differences and correlates of potential adoption of preexposure prophylaxis: results of a national survey. J Acquir Immune Defic Syndr. 2013;63(1):S95-101. https:\/\/doi.org\/10.1097\/QAI.0b013e3182920126.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4491_CR9","unstructured":"CDC. HIV and black\/African American people in the U.S. | fact sheets | newsroom | NCHHSTP | centesrs for disease control and prevention. https:\/\/www.cdc.gov\/nchhstp\/newsroom\/fact-sheetss\/hiv\/black-african-american-factsheet.html. Updated 2022."},{"issue":"3","key":"4491_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11524-015-9941-8","volume":"92","author":"HL Cooper","year":"2015","unstructured":"Cooper HL, Caruso B, Barham T, et al. Partner incarceration and African American women\u2019s sexual relationships and risk: a longitudinal qualitative study. J Urban Health. 2015;92(3):527\u201347. https:\/\/doi.org\/10.1007\/s11524-015-9941-8.","journal-title":"J Urban Health"},{"issue":"6","key":"4491_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/09540121.2016.1234679","volume":"29","author":"DB Garfinkel","year":"2017","unstructured":"Garfinkel DB, Alexander KA, McDonald-Mosley R, Willie TC, Decker MR. Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS care. 2017;29(6):751\u20138. https:\/\/doi.org\/10.1080\/09540121.2016.1234679.","journal-title":"AIDS care"},{"issue":"4","key":"4491_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/QAI.0000000000002042","volume":"81","author":"SK Calabrese","year":"2019","unstructured":"Calabrese SK, Willie TC, Galvao RW, et al. Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP. J Acquir Immune Defic Syndr. 2019;81(4):395\u2013405. https:\/\/doi.org\/10.1097\/QAI.0000000000002042.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4491_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1037\/a0032502","volume":"33","author":"L Rosenthal","year":"2014","unstructured":"Rosenthal L, Earnshaw VA, Lewis JB, et al. Discrimination and sexual risk among young urban pregnant women of color. Health Psychol. 2014;33(1):3\u201310. https:\/\/doi.org\/10.1037\/a0032502.","journal-title":"Health Psychol"},{"issue":"5","key":"4491_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1202614.","journal-title":"N Engl J Med"},{"key":"4491_CR15","unstructured":"Flash C, Stone VE, Mitty J, Mimiaga MJ, Hall KT, Krakower D. Acceptability of oral or vaginal HIV pre-exposure prophylaxis among at-risk black women in the United States. 2012."},{"issue":"7","key":"4491_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4172\/2155-6113.1000221.PMID:24455447;PMCID:PMC3895435","volume":"4","author":"KC Paxton","year":"2013","unstructured":"Paxton KC, Williams JK, Bolden S, Guzman Y, Harawa NT. HIV risk behaviors among African American women with at-risk male partners. J AIDS Clin Res. 2013;4(7):221. https:\/\/doi.org\/10.4172\/2155-6113.1000221.PMID:24455447;PMCID:PMC3895435.","journal-title":"J AIDS Clin Res"},{"issue":"5","key":"4491_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410. https:\/\/doi.org\/10.1056\/NEJMoa1108524.","journal-title":"N Engl J Med"},{"issue":"27","key":"4491_CR18","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399. https:\/\/doi.org\/10.1056\/NEJMoa1011205.","journal-title":"N Engl J Med."},{"key":"4491_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087674","author":"J Jiang","year":"2014","unstructured":"Jiang J, Yang X, Ye L, et al. Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials. PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0087674.","journal-title":"PLoS One"},{"key":"4491_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025828","author":"A Mujugira","year":"2011","unstructured":"Mujugira A, Baeten JM, Donnell D, et al. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS ONE. 2011. https:\/\/doi.org\/10.1371\/journal.pone.0025828.","journal-title":"PLoS ONE"},{"issue":"11","key":"4491_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1473-3099(14)70937-5","volume":"14","author":"JM Baeten","year":"2014","unstructured":"Baeten JM, Donnell D, Mugo NR, et al. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2014;14(11):1055\u201364. https:\/\/doi.org\/10.1016\/S1473-3099(14)70937-5.","journal-title":"Lancet Infect Dis"},{"issue":"9883","key":"4491_CR22","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in bangkok, thailand (the bangkok tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013;381(9883):2083\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(13)61127-7.","journal-title":"The Lancet"},{"issue":"2","key":"4491_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/COH.0b013e32834f5cf2","volume":"7","author":"MS Cohen","year":"2012","unstructured":"Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012;7(2):99\u2013105. https:\/\/doi.org\/10.1097\/COH.0b013e32834f5cf2.","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"4491_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/QAI.0000000000000172","volume":"66","author":"D Donnell","year":"2014","unstructured":"Donnell D, Baeten JM, Bumpus NN, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66(3):340\u20138. https:\/\/doi.org\/10.1097\/QAI.0000000000000172.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"4491_CR25","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1097\/QAD.0000000000000290","volume":"28","author":"PM Murnane","year":"2014","unstructured":"Murnane PM, Heffron R, Ronald A, et al. Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception. Aids. 2014;28(12):1825\u201330. https:\/\/doi.org\/10.1097\/QAD.0000000000000290.","journal-title":"Aids"},{"issue":"18","key":"4491_CR26","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1097\/QAD.0000000000000493","volume":"28","author":"R Heffron","year":"2014","unstructured":"Heffron R, Mugo N, Were E, et al. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception. AIDS. 2014;28(18):2771\u20136. https:\/\/doi.org\/10.1097\/QAD.0000000000000493.","journal-title":"AIDS"},{"issue":"6","key":"4491_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/15248399211053584","volume":"23","author":"NA Pilgrim","year":"2022","unstructured":"Pilgrim NA, Evans TM, Czarnogorski M. A layer plus approach to implementation research and collaboration for long-acting injectable preexposure prophylaxis for HIV prevention. Health Prom Prac. 2022;23(6):912\u20135. https:\/\/doi.org\/10.1177\/15248399211053584.","journal-title":"Health Prom Prac"},{"key":"4491_CR28","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach, 2nd ed. https:\/\/www.who.int\/publications-detail-redirect\/9789241549684. Updated 2016."},{"key":"4491_CR29","unstructured":"UNAIDS. Global AIDS strategy 2021\u20132026 \u2014 end inequalities. end AIDS. https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021-2026-global-AIDS-strategy. Updated 2021."},{"issue":"4","key":"4491_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10508-020-01903-8","volume":"50","author":"A Baldwin","year":"2021","unstructured":"Baldwin A, Light B, Allison WE. Pre-exposure prophylaxis (PrEP) for HIV infection in cisgender and transgender women in the US: a narrative review of the literature. Arch Sex Behav. 2021;50(4):1713\u201328. https:\/\/doi.org\/10.1007\/s10508-020-01903-8.","journal-title":"Arch Sex Behav"},{"issue":"12","key":"4491_CR31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","volume":"28","author":"AJ Siegler","year":"2018","unstructured":"Siegler AJ, Mouhanna F, Giler RM, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis\u2013to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841\u20139. https:\/\/doi.org\/10.1016\/j.annepidem.2018.06.005.","journal-title":"Ann Epidemiol"},{"issue":"1","key":"4491_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/QCO.0000000000000701","volume":"34","author":"J Thornhill","year":"2021","unstructured":"Thornhill J, Orkin C. Long-acting injectable HIV therapies: the next frontier. Curr Opin HIV AIDS. 2021;34(1):8\u201315. https:\/\/doi.org\/10.1097\/QCO.0000000000000701.","journal-title":"Curr Opin HIV AIDS."},{"key":"4491_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106220","author":"C Flexner","year":"2021","unstructured":"Flexner C, Owen A, Siccardi M, Swindells S. Long-acting drugs and formulations for the treatment and prevention of HIV infection. Int J Antimicrob Agent. 2021. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106220.","journal-title":"Int J Antimicrob Agent"},{"key":"4491_CR34","unstructured":"FDA. FDA approves first injectable treatment for HIV pre-exposure prevention. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention. Updated 2021."},{"issue":"7","key":"4491_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385(7):595\u2013608. https:\/\/doi.org\/10.1056\/NEJMoa2101016.","journal-title":"N Engl J Med"},{"issue":"2","key":"4491_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/COH.0000000000000030","volume":"9","author":"T Poteat","year":"2014","unstructured":"Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS. 2014;9(2):168\u201373. https:\/\/doi.org\/10.1097\/COH.0000000000000030.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"4491_CR37","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s10461-021-03571-8","volume":"26","author":"WC Irie","year":"2022","unstructured":"Irie WC, Calabrese SK, Patel RR, Mayer KH, Geng EH, Marcus JL. Preferences for HIV preexposure prophylaxis products among black women in the US. AIDS Behav. 2022;26(7):2212\u201323. https:\/\/doi.org\/10.1007\/s10461-021-03571-8.","journal-title":"AIDS Behav"},{"issue":"4","key":"4491_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/COH.0000000000000159","volume":"10","author":"K Meyers","year":"2015","unstructured":"Meyers K, Golub SA. Planning ahead for implementation of long-acting HIV prevention: challenges and opportunities. Curr Opin HIV AIDS. 2015;10(4):290\u20135. https:\/\/doi.org\/10.1097\/COH.0000000000000159.","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"4491_CR39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jana.2018.03.005","volume":"29","author":"CC Lambert","year":"2018","unstructured":"Lambert CC, Marrazzo J, Amico KR, Mugavero MJ, Elopre L. PrEParing women to prevent HIV: an integrated theoretical framework to PrEP black women in the United States. J Assoc Nurs AIDS Care. 2018;29(6):835\u201348. https:\/\/doi.org\/10.1016\/j.jana.2018.03.005.","journal-title":"J Assoc Nurs AIDS Care"},{"issue":"2","key":"4491_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/08964289.2019.1585325","volume":"45","author":"PA D\u2019Avanzo","year":"2019","unstructured":"D\u2019Avanzo PA, Bass SB, Brajuha J, et al. Medical mistrust and PrEP perceptions among transgender women: a cluster analysis. Behav Med. 2019;45(2):143\u201352. https:\/\/doi.org\/10.1080\/08964289.2019.1585325.","journal-title":"Behav Med"},{"issue":"41","key":"4491_CR41","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","volume":"67","author":"YA Huang","year":"2018","unstructured":"Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity\u2013United States, 2014\u20132016. MMWR Morb Mortal Wkly Rep. 2018;67(41):1147\u201350. https:\/\/doi.org\/10.15585\/mmwr.mm6741a3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"4491_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/QAI.0000000000001598","volume":"77","author":"P van Epps","year":"2018","unstructured":"van Epps P, Maier M, Lund B, et al. Medication adherence in a nationwide cohort of veterans initiating pre-exposure prophylaxis (PrEP) to prevent HIV infection. J Acquir Immune Defic Syndr. 2018;77(3):272\u20138. https:\/\/doi.org\/10.1097\/QAI.0000000000001598.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"4491_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11121-017-0756-6","volume":"18","author":"LA Eaton","year":"2017","unstructured":"The POWER Study Team, Eaton LA, Matthews DD, et al. A multi-US city assessment of awareness and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among black men and transgender women who have sex with men. Prev Sci. 2017;18(5):505\u201316. https:\/\/doi.org\/10.1007\/s11121-017-0756-6.","journal-title":"Prev Sci"},{"key":"4491_CR44","unstructured":"Mera R, McCallister S, Palmer B, Mayer G, Magnuson D, Rawlings K. FTC\/TDF (truvada) for HIV pre-exposure prophylaxis (PrEP) utilization in the united states:2013\u20132015. 2016."},{"key":"4491_CR45","unstructured":"Smith DK, Van Handel M, Grey JA. By race\/ethnicity, blacks had the highest number needing PrEP in the US in 2015. 2018."},{"issue":"6","key":"4491_CR46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1402269.","journal-title":"N Engl J Med"},{"key":"4491_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064038","author":"I Young","year":"2013","unstructured":"Young I, Li J, McDaid L. Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in Scotland: implications for biomedical HIV prevention. PLoS One. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0064038.","journal-title":"PLoS One"},{"issue":"2","key":"4491_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/ciw701","volume":"64","author":"H Wu","year":"2017","unstructured":"Wu H, Mendoza MCB, Huang YA, Hayes T, Smith DK, Hoover KW. Uptake of HIV preexposure prophylaxis among commercially insured persons\u2014United states, 2010\u20132014. CLINID. 2017;64(2):144\u20139. https:\/\/doi.org\/10.1093\/cid\/ciw701.","journal-title":"CLINID"},{"issue":"1","key":"4491_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/QAI.0000000000001879","volume":"80","author":"JR Raifman","year":"2019","unstructured":"Raifman JR, Schwartz SR, Sosnowy CD, et al. Brief report: pre-exposure prophylaxis awareness and use among cisgender women at a sexually transmitted disease clinic. J Acquir Immune Defic Syndr. 2019;80(1):36\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000001879.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"4491_CR50","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s10461-019-02573-x","volume":"23","author":"C Zhang","year":"2019","unstructured":"Zhang C, McMahon J, Simmons J, Brown LL, Nash R, Liu Y. Suboptimal HIV pre-exposure prophylaxis awareness and willingness to use among women who use drugs in the united states: a systematic review and meta-analysis. AIDS Behav. 2019;23(10):2641\u201353. https:\/\/doi.org\/10.1007\/s10461-019-02573-x.","journal-title":"AIDS Behav."},{"issue":"2","key":"4491_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1300\/J013v38n02_04","volume":"38","author":"H Klein","year":"2003","unstructured":"Klein H, Elifson KW, Sterk CE. \u201cAt risk\u201d women who think that they have no chance of getting HIV: Self-assessed perceived risks. Women Health. 2003;38(2):47\u201363. https:\/\/doi.org\/10.1300\/J013v38n02_04.","journal-title":"Women Health"},{"issue":"10","key":"4491_CR52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/apc.2013.0013","volume":"27","author":"K Pringle","year":"2013","unstructured":"Pringle K, Merchant RC, Clark MA. Is self-perceived HIV risk congruent with reported HIV risk among traditionally lower HIV risk and prevalence adult emergency department patients? Implications for HIV testing. AIDS Patient Care STDS. 2013;27(10):573\u201384. https:\/\/doi.org\/10.1089\/apc.2013.0013.","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"4491_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/10810730.2016.1261969","volume":"22","author":"KL Collier","year":"2017","unstructured":"Collier KL, Colarossi LG, Sanders K. Raising awareness of pre-exposure prophylaxis (PrEP) among women in New York city: community and provider perspectives. J Health Commun. 2017;22(3):183\u20139. https:\/\/doi.org\/10.1080\/10810730.2016.1261969.","journal-title":"J Health Commun."},{"key":"4491_CR54","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000730","author":"L Goparaju","year":"2017","unstructured":"Goparaju L, Praschan NC, Warren-Jeanpiere L, Experton LS, Young MA, Kassaye S. Stigma, partners, providers, and costs: potential barriers to PrEP uptake among US women. J AIDS Clin Res. 2017. https:\/\/doi.org\/10.4172\/2155-6113.1000730.","journal-title":"J AIDS Clin Res"},{"issue":"9","key":"4491_CR55","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/infdis\/jiz416","volume":"222","author":"BO Ojikutu","year":"2020","unstructured":"Ojikutu BO, Mayer KH. Hidden in plain sight: Identifying women living in the United States who could benefit from HIV preexposure prophylaxis. J Infect Dis. 2020;222(9):1428\u201331. https:\/\/doi.org\/10.1093\/infdis\/jiz416.","journal-title":"J Infect Dis"},{"issue":"11","key":"4491_CR56","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s10461-018-2102-9","volume":"22","author":"CT Rael","year":"2018","unstructured":"Rael CT, Martinez M, Giguere R, et al. Barriers and facilitators to oral PrEP use among transgender women in New York city. AIDS Behav. 2018;22(11):3627\u201336. https:\/\/doi.org\/10.1007\/s10461-018-2102-9.","journal-title":"AIDS Behav"},{"issue":"10","key":"4491_CR57","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/09540121.2018.1447079","volume":"30","author":"R Rutledge","year":"2018","unstructured":"Rutledge R, Madden L, Ogbuagu O, Meyer JP. HIV risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system. AIDS care. 2018;30(10):1282\u20139. https:\/\/doi.org\/10.1080\/09540121.2018.1447079.","journal-title":"AIDS care"},{"issue":"11","key":"4491_CR58","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1177\/0956462416686722","volume":"28","author":"LF Salazar","year":"2017","unstructured":"Salazar LF, Crosby RA, Jones J, Kota K, Hill B, Masyn KE. Contextual, experiential, and behavioral risk factors associated with HIV status: a descriptive analysis of transgender women residing in Atlanta Georgia. Int J STD AIDS. 2017;28(11):1059\u201366. https:\/\/doi.org\/10.1177\/0956462416686722.","journal-title":"Int J STD AIDS"},{"issue":"7\u20138","key":"4491_CR59","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/17441692.2016.1154085","volume":"11","author":"JM Sevelius","year":"2016","unstructured":"Sevelius JM, Keatley J, Calma N, Arnold E. \u201cI am not a man\u201d: trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7\u20138):1060\u201375. https:\/\/doi.org\/10.1080\/17441692.2016.1154085.","journal-title":"Glob Public Health"},{"issue":"11","key":"4491_CR60","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1089\/apc.2017.0171","volume":"31","author":"SJ Marks","year":"2017","unstructured":"Marks SJ, Merchant RC, Clark MA, et al. Potential healthcare insurance and provider barriers to pre-exposure prophylaxis utilization among young men who have sex with men. AIDS Patient Care STDS. 2017;31(11):470\u20138. https:\/\/doi.org\/10.1089\/apc.2017.0171.","journal-title":"AIDS Patient Care STDS"},{"key":"4491_CR61","unstructured":"Ndugga N, Artiga S, Orgera K. Disparities in health and health care: 5 key questions and answers. https:\/\/www.kff.org\/racial-equity-and-health-policy\/issue-brief\/disparities-in-health-and-health-care-5-key-question-and-answers\/. Updated 2023."},{"issue":"5","key":"4491_CR62","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000001950","volume":"80","author":"AS Patel","year":"2019","unstructured":"Patel AS, Goparaju L, Sales JM, et al. Brief report: PrEP eligibility among at-risk women in the southern United States: associated factors, awareness, and acceptability. J Acquir Immune Defic Syndr. 2019;80(5):527\u201332. https:\/\/doi.org\/10.1097\/QAI.0000000000001950.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4491_CR63","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/10410236.2016.1140271","volume":"32","author":"J Schwartz","year":"2017","unstructured":"Schwartz J, Grimm J. PrEP on twitter: information, barriers, and stigma. Health Commun. 2017;32(4):509\u201316. https:\/\/doi.org\/10.1080\/10410236.2016.1140271.","journal-title":"Health Commun"},{"key":"4491_CR64","unstructured":"CDC. Do you have health insurance? | paying for PrEP | PrEP | HIV basics | HIV\/AIDS | CDC. https:\/\/www.cdc.gov\/hiv\/basics\/prep\/paying-for-prep\/index.html. Updated 2022."},{"issue":"3","key":"4491_CR65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/hsw\/29.3.219","volume":"29","author":"G Kadushin","year":"2004","unstructured":"Kadushin G. Home health care utilization: a review of the research for social work. Health Social Work. 2004;29(3):219\u201344. https:\/\/doi.org\/10.1093\/hsw\/29.3.219.","journal-title":"Health Social Work."},{"issue":"1","key":"4491_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10597-009-9253-0","volume":"47","author":"L Hochhausen","year":"2011","unstructured":"Hochhausen L, Le H, Perry DF. Community-based mental health service utilization among low-income latina immigrants. Commun Ment Health J. 2011;47(1):14\u201323. https:\/\/doi.org\/10.1007\/s10597-009-9253-0.","journal-title":"Commun Ment Health J"},{"issue":"3","key":"4491_CR67","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S1473-3099(12)70315-8","volume":"13","author":"SD Baral","year":"2013","unstructured":"Baral SD, Poteat T, Str\u00f6mdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214\u201322. https:\/\/doi.org\/10.1016\/S1473-3099(12)70315-8.","journal-title":"Lancet Infect Dis"},{"key":"4491_CR68","doi-asserted-by":"publisher","DOI":"10.4159\/9780674028845","volume-title":"The ecology of human development: experiments by nature and design","author":"U Bronfenbrenner","year":"1979","unstructured":"Bronfenbrenner U. The ecology of human development: experiments by nature and design. Cambridge: Harvard University Press; 1979."},{"issue":"10","key":"4491_CR69","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2105\/AJPH.2015.302816","volume":"105","author":"SK Calabrese","year":"2015","unstructured":"Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize \u201cTruvada whores.\u201d Am J Public Health. 2015;105(10):1960\u20134. https:\/\/doi.org\/10.2105\/AJPH.2015.302816.","journal-title":"Am J Public Health"},{"issue":"1","key":"4491_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/COH.0000000000000206","volume":"11","author":"DS Krakower","year":"2016","unstructured":"Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):41\u20138. https:\/\/doi.org\/10.1097\/COH.0000000000000206.","journal-title":"Curr Opin HIV AIDS"},{"key":"4491_CR71","doi-asserted-by":"publisher","DOI":"10.2196\/12405","author":"BO Ojikutu","year":"2019","unstructured":"Ojikutu BO, Bogart LM, Mayer KH, Stopka TJ, Sullivan PS, Ransome Y. Spatial access and willingness to use pre-exposure prophylaxis among black\/african american individuals in the united states: cross-sectional survey. JMIR Public Health Surveill. 2019. https:\/\/doi.org\/10.2196\/12405.","journal-title":"JMIR Public Health Surveill"},{"key":"4491_CR72","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.1.19052","author":"JO Parkhurst","year":"2014","unstructured":"Parkhurst JO. Structural approaches for prevention of sexually transmitted HIV in general populations: definitions and an operational approach. J Int AIDS Soc. 2014. https:\/\/doi.org\/10.7448\/IAS.17.1.19052.","journal-title":"J Int AIDS Soc"},{"issue":"9964","key":"4491_CR73","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0140-6736(14)60833-3","volume":"385","author":"T Poteat","year":"2015","unstructured":"Poteat T, Wirtz AL, Radix A, et al. HIV risk and preventive interventions in transgender women sex workers. The Lancet. 2015;385(9964):274\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(14)60833-3.","journal-title":"The Lancet"},{"key":"4491_CR74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.healthplace.2016.09.004","volume":"42","author":"Y Ransome","year":"2016","unstructured":"Ransome Y, Kawachi I, Braunstein S, Nash D. Structural inequalities drive late HIV diagnosis: the role of black racial concentration, income inequality, socioeconomic deprivation, and HIV testing. Health & Place. 2016;42:148\u201358. https:\/\/doi.org\/10.1016\/j.healthplace.2016.09.004.","journal-title":"Health & Place"},{"issue":"3","key":"4491_CR75","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10461-016-1581-9","volume":"21","author":"Y Ransome","year":"2017","unstructured":"Ransome Y, Kawachi I, Dean LT. Neighborhood social capital in relation to late HIV diagnosis, linkage to HIV care, and HIV care engagement. AIDS Behav. 2017;21(3):891\u2013904. https:\/\/doi.org\/10.1007\/s10461-016-1581-9.","journal-title":"AIDS Behav"},{"issue":"2","key":"4491_CR76","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/QAI.0000000000002112","volume":"82","author":"T Poteat","year":"2019","unstructured":"Poteat T, Wirtz A, Malik M, et al. A gap between willingness and uptake: findings from mixed methods research on HIV prevention among black and latina transgender women. J Acquir Immune Defic Syndr. 2019;82(2):131\u201340. https:\/\/doi.org\/10.1097\/QAI.0000000000002112.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"4491_CR77","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/cid\/civ664","volume":"61","author":"CF Kelley","year":"2015","unstructured":"Kelley CF, Kahle E, Siegler A, et al. Applying a PrEP continuum of care for men who have sex with men in atlanta, georgia. Clin Infect Dis. 2015;61(10):1590\u20137. https:\/\/doi.org\/10.1093\/cid\/civ664.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4491_CR78","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2105\/AJPH.2018.304656","volume":"108","author":"SK Calabrese","year":"2018","unstructured":"Calabrese SK. Interpreting gaps along the preexposure prophylaxis cascade and addressing vulnerabilities to stigma. Am J Public Health. 2018;108(10):1284\u20136. https:\/\/doi.org\/10.2105\/AJPH.2018.304656.","journal-title":"Am. J. Public Health."},{"issue":"5","key":"4491_CR79","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","volume":"31","author":"AS Nunn","year":"2017","unstructured":"Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017;31(5):731\u20134. https:\/\/doi.org\/10.1097\/QAD.0000000000001385.","journal-title":"AIDS"},{"issue":"10","key":"4491_CR80","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/apc.2013.0173","volume":"27","author":"D Tellalian","year":"2013","unstructured":"Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27(10):553\u20139. https:\/\/doi.org\/10.1089\/apc.2013.0173.","journal-title":"AIDS Patient Care STDS"},{"issue":"12","key":"4491_CR81","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1089\/apc.2018.0030","volume":"32","author":"DE Koren","year":"2018","unstructured":"Koren DE, Nichols JS, Simoncini GM. HIV pre-exposure prophylaxis and women: survey of the knowledge, attitudes, and beliefs in an urban obstetrics\/gynecology clinic. AIDS Patient Care STDS. 2018;32(12):490\u20134. https:\/\/doi.org\/10.1089\/apc.2018.0030.","journal-title":"AIDS Patient Care STDS"},{"issue":"11","key":"4491_CR82","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1007\/s10461-018-2067-8","volume":"22","author":"BO Ojikutu","year":"2018","unstructured":"Ojikutu BO, Bogart LM, Higgins-Biddle M, et al. Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: results from the national survey on HIV in the black community (NSHBC). AIDS Behav. 2018;22(11):3576\u201387. https:\/\/doi.org\/10.1007\/s10461-018-2067-8.","journal-title":"AIDS Behav"},{"issue":"10","key":"4491_CR83","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0956462415601304","volume":"27","author":"S Doblecki-Lewis","year":"2016","unstructured":"Doblecki-Lewis S, Lester L, Schwartz B, Collins C, Johnson R, Kobetz E. HIV risk and awareness and interest in pre-exposure and post-exposure prophylaxis among sheltered women in Miami. Int J STD AIDS. 2016;27(10):873\u201381. https:\/\/doi.org\/10.1177\/0956462415601304.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"4491_CR84","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0000000000001605","volume":"77","author":"CA Flash","year":"2018","unstructured":"Flash CA, Adegboyega OO, Yu X, et al. Correlates of linkage to HIV pre-exposure prophylaxis (PrEP) among HIV testing clients. J Acquir Immune Defic Syndr. 2018;77(4):365\u201372. https:\/\/doi.org\/10.1097\/QAI.0000000000001605.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4491_CR85","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1089\/apc.2011.0202","volume":"26","author":"T Khawcharoenporn","year":"2012","unstructured":"Khawcharoenporn T, Kendrick S, Smith K. HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care STDS. 2012;26(4):222\u201333. https:\/\/doi.org\/10.1089\/apc.2011.0202.","journal-title":"AIDS Patient Care STDS"},{"key":"4491_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/HIV.S33445","volume":"4","author":"B Peng","year":"2012","unstructured":"Peng B, Yang X, Zhang Y, et al. Willingness to use pre-exposure prophylaxis for HIV prevention among female sex workers: a cross-sectional study in China. HIV AIDS (Auckl). 2012;4:149\u201358. https:\/\/doi.org\/10.2147\/HIV.S33445.","journal-title":"HIV AIDS (Auckl)"},{"issue":"2","key":"4491_CR87","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S2352-3018(16)30207-7","volume":"4","author":"M Martin","year":"2017","unstructured":"Martin M, Vanichseni S, Suntharasamai P, et al. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok tenofovir study. Lancet HIV. 2017;4(2):e59-66. https:\/\/doi.org\/10.1016\/S2352-3018(16)30207-7.","journal-title":"Lancet HIV"},{"issue":"14","key":"4491_CR88","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1080\/10826084.2020.1823419","volume":"55","author":"SM Walters","year":"2020","unstructured":"Walters SM, Kral AH, Simpson KA, Wenger L, Bluthenthal RN. HIV pre-exposure prophylaxis prevention awareness, willingness, and perceived barriers among people who inject drugs in Los Angeles and San Francisco, CA, 2016\u20132018. Subst Use Misuse. 2020;55(14):2409\u201319. https:\/\/doi.org\/10.1080\/10826084.2020.1823419.","journal-title":"Subst Use Misuse"},{"key":"4491_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08019-z","author":"MJ Hill","year":"2023","unstructured":"Hill MJ, Heads AM, Suchting R, Stotts AL. A survey with interventional components delivered on tablet devices versus usual care to increase pre-exposure prophylaxis uptake among cisgender black women: a pilot randomized controlled trial. BMC Infect Dis. 2023. https:\/\/doi.org\/10.1186\/s12879-023-08019-z.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"4491_CR90","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10461-016-1407-9","volume":"20","author":"HA Kwakwa","year":"2016","unstructured":"Kwakwa HA, Bessias S, Sturgis D, et al. Attitudes toward HIV pre-exposure prophylaxis in a united states urban clinic population. AIDS Behav. 2016;20(7):1443\u201350. https:\/\/doi.org\/10.1007\/s10461-016-1407-9.","journal-title":"AIDS Behav"},{"key":"4491_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128971","author":"EC Wilson","year":"2015","unstructured":"Wilson EC, Jin H, Liu A, Raymond HF. Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco 2013. PLoS One. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0128971.","journal-title":"PLoS One"},{"issue":"1","key":"4491_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2137284","volume":"36","author":"RM Andersen","year":"1995","unstructured":"Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1\u201310.","journal-title":"J Health Soc Behav"},{"issue":"6","key":"4491_CR93","first-page":"1273","volume":"34","author":"L Gelberg","year":"2000","unstructured":"Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273\u2013302.","journal-title":"Health Serv Res"},{"issue":"4","key":"4491_CR94","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/QAI.0000000000000479","volume":"68","author":"SE Cohen","year":"2015","unstructured":"Cohen SE, Vittinghoff E, Bacon O, et al. High interest in pre-exposure prophylaxis among men who have sex with men at risk for HIV-infection: Baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2015;68(4):439\u201348. https:\/\/doi.org\/10.1097\/QAI.0000000000000479.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"4491_CR95","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s10461-016-1353-6","volume":"20","author":"WC Goedel","year":"2016","unstructured":"Goedel WC, Halkitis PN, Greene RE, Duncan DT. Correlates of awareness of and willingness to use pre-exposure prophylaxis (PrEP) in gay, bisexual, and other men who have sex with men who use geosocial-networking smartphone applications in New York city. AIDS Behav. 2016;20(7):1435\u201342. https:\/\/doi.org\/10.1007\/s10461-016-1353-6.","journal-title":"AIDS Behav"},{"issue":"5","key":"4491_CR96","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1007\/s10461-016-1516-5","volume":"21","author":"B Hoagland","year":"2017","unstructured":"Hoagland B, De Boni RB, Moreira RI, et al. Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017;21(5):1278\u201387. https:\/\/doi.org\/10.1007\/s10461-016-1516-5.","journal-title":"AIDS Behav"},{"issue":"3","key":"4491_CR97","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/QAD.0000000000000937","volume":"30","author":"JE Hood","year":"2016","unstructured":"Hood JE, Buskin SE, Dombrowski JC, et al. Dramatic increase in preexposure prophylaxis use among MSM in washington state. AIDS. 2016;30(3):515\u20139. https:\/\/doi.org\/10.1097\/QAD.0000000000000937.","journal-title":"AIDS"},{"issue":"9","key":"4491_CR98","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s10461-014-0845-5","volume":"18","author":"HL King","year":"2014","unstructured":"King HL, Keller SB, Giancola MA, et al. Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE study). AIDS Behav. 2014;18(9):1722\u20135. https:\/\/doi.org\/10.1007\/s10461-014-0845-5.","journal-title":"AIDS Behav"},{"issue":"2","key":"4491_CR99","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10461-013-0560-7","volume":"18","author":"I Young","year":"2014","unstructured":"Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195\u2013216. https:\/\/doi.org\/10.1007\/s10461-013-0560-7.","journal-title":"AIDS Behav"},{"issue":"7","key":"4491_CR100","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1007\/s10461-016-1379-9","volume":"20","author":"L Ferrer","year":"2016","unstructured":"Ferrer L, Folch C, Fernandez-Davila P, et al. Awareness of pre-exposure prophylaxis for HIV, willingness to use it and potential barriers or facilitators to uptake among men who have sex with men in spain. AIDS Behav. 2016;20(7):1423\u201333. https:\/\/doi.org\/10.1007\/s10461-016-1379-9.","journal-title":"AIDS Behav"},{"key":"4491_CR101","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","volume":"164","author":"I Kuo","year":"2016","unstructured":"Kuo I, Olsen H, Patrick R, et al. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington. DC Drug Alcohol Depend. 2016;164:8\u201313. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.044.","journal-title":"DC Drug Alcohol Depend"},{"issue":"9","key":"4491_CR102","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","volume":"18","author":"M Stein","year":"2014","unstructured":"Stein M, Thurmond P, Bailey G. Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS Behav. 2014;18(9):1694\u2013700. https:\/\/doi.org\/10.1007\/s10461-014-0778-z.","journal-title":"AIDS Behav"},{"issue":"5","key":"4491_CR103","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s10461-017-1690-0","volume":"21","author":"LA Eaton","year":"2017","unstructured":"Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS Behav. 2017;21(5):1236\u201346. https:\/\/doi.org\/10.1007\/s10461-017-1690-0.","journal-title":"AIDS Behav"},{"issue":"4","key":"4491_CR104","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/apc.2012.0419","volume":"27","author":"SA Golub","year":"2013","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in new york city. AIDS Patient Care STDS. 2013;27(4):248\u201354. https:\/\/doi.org\/10.1089\/apc.2012.0419.","journal-title":"AIDS Patient Care STDS"},{"key":"4491_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015. https:\/\/doi.org\/10.1186\/2046-4053-4-1.","journal-title":"Syst Rev"},{"key":"4491_CR106","doi-asserted-by":"publisher","DOI":"10.4103\/IJCN.IJCN_140_20","author":"S Durai","year":"2021","unstructured":"Durai S. Building blocks: the art and science of searching the literature. Indian J Cont Nurs Educ. 2021. https:\/\/doi.org\/10.4103\/IJCN.IJCN_140_20.","journal-title":"Indian J Cont Nurs Educ"},{"key":"4491_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"key":"4491_CR108","unstructured":"Higgins J, Morgan R, Rooney A, et al. Risk of bias tools - ROBINS-E tool. https:\/\/www.riskofbias.info\/welcome\/robins-e-tool. Updated 2023."},{"key":"4491_CR109","unstructured":"Ryan R, Hill S. How to GRADE the quality of the evidence. 2016. http:\/\/cccrg.cochrane.org\/author-resources."},{"issue":"4","key":"4491_CR110","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"key":"4491_CR111","unstructured":"Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews: A product from the ESRC methods programme.; 2006."},{"issue":"2","key":"4491_CR112","doi-asserted-by":"publisher","first-page":"91","DOI":"10.7748\/nr.13.2.91.s14","volume":"13","author":"J Lathlean","year":"2005","unstructured":"Lathlean J. Qualitative methods for health research J judith green qualitative methods for health research and NickiThorogood sage 280 \u00a319.99076194771X. Nurse Res. 2005;13(2):91\u20132.","journal-title":"Nurse Res."},{"key":"4491_CR113","volume-title":"Basics of qualitative research: grounded theory procedures and technique","author":"A Strauss","year":"1990","unstructured":"Strauss A, Corbin JM. Basics of qualitative research: grounded theory procedures and technique. Thousand Oaks: Sage Publications; 1990."},{"key":"4491_CR114","volume-title":"Social research methods","author":"A Bryman","year":"2012","unstructured":"Bryman A. Social research methods. 5th ed. Oxford: Oxford University Press; 2012.","edition":"5"},{"key":"4491_CR115","unstructured":"Charmaz K, Lincoln Y, Denzin N. Grounded theory: Objectivist and constructivist methods. In: Handbook of qualitative research. ; 2000:509\u2013535. https:\/\/www.researchgate.net\/publication\/272787056_Grounded_Theory_Objectivist_and_Constructivist_Methods."},{"key":"4491_CR116","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"1","key":"4491_CR117","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Method. 2021;12(1):55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411.","journal-title":"Res Synth Method"},{"key":"4491_CR118","unstructured":"Cochrane handbook for systematic reviews of interventions. Repr. with corr ed. Chichester, West Sussex: John Wiley & Sons; 2009:649."},{"key":"4491_CR119","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jclinepi.2015.08.013","volume":"70","author":"A Pollock","year":"2016","unstructured":"Pollock A, Farmer SE, Brady MC, et al. An algorithm was developed to assign GRADE levels of evidence to comparisons within systematic reviews. J Clin Epidemiol. 2016;70:106\u201310. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.08.013.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"4491_CR120","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","volume":"21","author":"AE Petroll","year":"2017","unstructured":"Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256\u201367. https:\/\/doi.org\/10.1007\/s10461-016-1625-1.","journal-title":"AIDS Behav"},{"key":"4491_CR121","doi-asserted-by":"publisher","DOI":"10.18865\/ed.28.2.85","author":"A Nunn","year":"2018","unstructured":"Nunn A, Parker S, McCoy K, et al. African American clergy perspectives about the HIV care continuum: results from a qualitative study in Jackson Mississippi. Ethn Dis. 2018. https:\/\/doi.org\/10.18865\/ed.28.2.85.","journal-title":"Ethn Dis"},{"key":"4491_CR122","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.3.19146","author":"A Van Der Straten","year":"2014","unstructured":"Van Der Straten A, Stadler J, Luecke E, et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, south Africa. J Int AIDS Soc. 2014. https:\/\/doi.org\/10.7448\/IAS.17.3.19146.","journal-title":"J Int AIDS Soc."},{"issue":"1","key":"4491_CR123","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","volume":"176","author":"AY Liu","year":"2016","unstructured":"Liu AY, Cohen SE, Vittinghoff E, et al. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176(1):75\u201384. https:\/\/doi.org\/10.1001\/jamainternmed.2015.4683.","journal-title":"JAMA Intern Med"},{"key":"4491_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06786-1","author":"TC Willie","year":"2021","unstructured":"Willie TC, Monger M, Nunn A, et al. \u201cPrEP\u2019s just to secure you like insurance\u201d: a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi. BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/s12879-021-06786-1.","journal-title":"BMC Infect Dis"},{"key":"4491_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234821","author":"T Taggart","year":"2020","unstructured":"Taggart T, Liang Y, Pina P, Albritton T. Awareness of and willingness to use PrEP among black and latinx adolescents residing in higher prevalence areas in the United States. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0234821.","journal-title":"PLoS ONE."},{"issue":"1","key":"4491_CR126","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10461-023-04188-9","volume":"28","author":"AI Sophus","year":"2024","unstructured":"Sophus AI, Mitchell JW, Barroso J, Sales JM. Factors associated with planned future use of PrEP in the next 3 months and likelihood to use PrEP among black cisgender HIV-negative women in texas. AIDS Behav. 2024;28(1):72\u201392. https:\/\/doi.org\/10.1007\/s10461-023-04188-9.","journal-title":"AIDS Behav."},{"issue":"7","key":"4491_CR127","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s10461-018-2283-2","volume":"23","author":"M Tekeste","year":"2019","unstructured":"Tekeste M, Hull S, Dovidio JF, et al. Differences in medical mistrust between black and white women: implications for patient-provider communication about PrEP. AIDS Behav. 2019;23(7):1737\u201348. https:\/\/doi.org\/10.1007\/s10461-018-2283-2.","journal-title":"AIDS Behav"},{"issue":"7","key":"4491_CR128","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10461-015-1226-4","volume":"20","author":"CE Oldenburg","year":"2016","unstructured":"Oldenburg CE, Mitty JA, Biello KB, et al. Differences in attitudes about HIV pre-exposure prophylaxis use among stimulant versus alcohol using men who have sex with men. AIDS Behav. 2016;20(7):1451\u201360. https:\/\/doi.org\/10.1007\/s10461-015-1226-4.","journal-title":"AIDS Behav"},{"issue":"4","key":"4491_CR129","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1007\/s10461-021-03488-2","volume":"26","author":"SM Walters","year":"2022","unstructured":"Walters SM, Frank D, Van Ham B, et al. PrEP care continuum engagement among persons who inject drugs: rural and urban differences in stigma and social infrastructure. AIDS Behav. 2022;26(4):1308\u201320. https:\/\/doi.org\/10.1007\/s10461-021-03488-2.","journal-title":"AIDS Behav"},{"issue":"4","key":"4491_CR130","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/OLQ.0000000000000728","volume":"45","author":"AM Roth","year":"2018","unstructured":"Roth AM, Aumaier BL, Felsher MA, et al. An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users. Sexual Trans Dis. 2018;45(4):217\u201321. https:\/\/doi.org\/10.1097\/OLQ.0000000000000728.","journal-title":"Sexual Trans Dis."},{"issue":"5","key":"4491_CR131","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/QAI.0000000000001532","volume":"76","author":"DK Smith","year":"2017","unstructured":"Smith DK, Van Handel M, Huggins R. Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States 2015. J Acquir Immune Defic Syndr. 2017;76(5):465\u201372. https:\/\/doi.org\/10.1097\/QAI.0000000000001532.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4491_CR132","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/JNC.0000000000000070","volume":"30","author":"CJ Park","year":"2019","unstructured":"Park CJ, Taylor TN, Gutierrez NR, Zingman BS, Blackstock OJ. Pathways to HIV pre-exposure prophylaxis among women prescribed PrEP at an urban sexual health clinic. J Acquir Immune Defic Syndr. 2019;30(3):321\u20139. https:\/\/doi.org\/10.1097\/JNC.0000000000000070.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"4491_CR133","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/QAI.0000000000000880","volume":"71","author":"A Corneli","year":"2016","unstructured":"Corneli A, Perry B, McKenna K, et al. Participants\u2019 explanations for nonadherence in the FEM-PrEP clinical trial. J Acquir Immune Defic Syndr. 2016;71(4):452\u201361. https:\/\/doi.org\/10.1097\/QAI.0000000000000880.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"4491_CR134","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778\u2013811. https:\/\/doi.org\/10.1007\/s12325-020-01295-0.","journal-title":"Adv. Ther."},{"key":"4491_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed8090436","author":"WC Irie","year":"2023","unstructured":"Irie WC, Mahone A, Nakka R, Ghebremichael M. Factors associated with comfort discussing PrEP with healthcare providers among black cisgender women. TropicalMed. 2023. https:\/\/doi.org\/10.3390\/tropicalmed8090436.","journal-title":"TropicalMed"},{"key":"4491_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-6314-8","author":"AR Bazzi","year":"2019","unstructured":"Bazzi AR, Drainoni M, Biancarelli DL, et al. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019. https:\/\/doi.org\/10.1186\/s12889-018-6314-8.","journal-title":"BMC Public Health"},{"issue":"7","key":"4491_CR137","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10508-017-1100-8","volume":"47","author":"K Underhill","year":"2018","unstructured":"Underhill K, Guthrie KM, Colleran C, Calabrese SK, Operario D, Mayer KH. Temporal fluctuations in behavior, perceived HIV risk, and willingness to use pre-exposure prophylaxis (PrEP). Arch Sex Behav. 2018;47(7):2109\u201321. https:\/\/doi.org\/10.1007\/s10508-017-1100-8.","journal-title":"Arch Sex Behav"},{"key":"4491_CR138","unstructured":"NIAID National Institute of Allergy and Infectious Diseases. National Institutes of Health. NIH Statement on Preliminary Efficacy Results of Twice-Yearly Lenacapavir for HIV Prevention in Cisgender Women. 2024. https:\/\/www.niaid.nih.gov\/news-events\/nih-statement-preliminary-efficacy-results-twice-yearly-lenacapavir-hiv-prevention"},{"issue":"1","key":"4491_CR139","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1037\/a0030449","volume":"60","author":"JH Hammer","year":"2013","unstructured":"Hammer JH, Vogel DL. Assessing the utility of the willingness\/prototype model in predicting help-seeking decisions. J Couns Psychol. 2013;60(1):83\u201397. https:\/\/doi.org\/10.1037\/a0030449.","journal-title":"J Couns Psychol"},{"issue":"3","key":"4491_CR140","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1348\/135910705X70327","volume":"11","author":"A Rivis","year":"2006","unstructured":"Rivis A, Sheeran P, Armitage CJ. Augmenting the theory of planned behaviour with the prototype\/willingness model: predictive validity of actor versus abstainer prototypes for adolescents\u2019 health-protective and health-risk intentions. Br J Health Psychol. 2006;11(3):483\u2013500. https:\/\/doi.org\/10.1348\/135910705X70327.","journal-title":"Br J Health Psychol"},{"issue":"7","key":"4491_CR141","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0146167209335166","volume":"35","author":"EA Pomery","year":"2009","unstructured":"Pomery EA, Gibbons FX, Reis-Bergan M, Gerrard M. From willingness to intention: experience moderates the shift from reactive to reasoned behavior. Pers Soc Psychol Bull. 2009;35(7):894\u2013908. https:\/\/doi.org\/10.1177\/0146167209335166.","journal-title":"Pers Soc Psychol Bull"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04491-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-024-04491-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-024-04491-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T01:28:23Z","timestamp":1737077303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-024-04491-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":141,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4491"],"URL":"https:\/\/doi.org\/10.1007\/s10461-024-04491-z","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"24 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest relevant to this article. There are no competing financial or nonfinancial interests that could potentially influence the work presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This was an observational review study; thus, no ethical approval was required. The authors adhered to the minimum standards and reporting guidelines for systematic review articles by systematic reviews and meta-analyses (PRISMA), and protocols (Prisma-P).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies involving human participants or animals performed by any of the authors. Consequently, this study was exempt from Institutional Review Board (IRB) review and ethics approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animal Rights"}},{"value":"Informed consent was not obtained for this study. This systematic review did not involve human participants; therefore, consent for participation was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors consent to the publication of the data and images submitted in this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}